Today there are many scales to choose from. Psychiatrists familiar with these tools will be better able to interpret clinical trial results and to employ them in assessing patients’ clinical progress. Here we review the most commonly used depression rating scales, as well as some newer web-based tools.
You greet a new patient who complains of difficulty concentrating at work and is unable to “keep up” since making partner at a law firm or becoming an attending physician at a hospital. Is this an authentic case of a high-functioning person with undiagnosed adult ADHD, a subtle request for performance enhancement, or something altogether different?
Terence Keane, PhD
Professor and assistant dean for research, Boston University School of Medicine, Associate chief of staff for research & development, VA Boston Healthcare System
Dr. Keane has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
PTDS is one of the greatest mental health concerns in veterans, but there is a stigma, among veterans, on issues related to seeking mental health services. Dr. Kean discusses effective screening methods, current findings and treatment options.
Do you know what other medications your depressed patients are taking? You should. If they’re taking non-steroidal anti-inflammatory drugs (NSAIDs), they may be less likely to respond to SSRIs.
Chronic pain is typically defined as pain lasting longer than three months, resulting from either a disease process or bodily injury that has not resolved as expected. It is a major and complex public health reality for almost one-third of the US population.
How often are you faced with patients who come to you with “I’m exhausted,” “I have no energy,” “I’m dragging,” or “I can’t stay awake”? If you’re like most psychiatrists, you see this often, and at times simply giving a sleep aid is an unsatisfying or ineffective solution.
Since our feature article on “New Antidepressants” in the May 2012 TCPR, you may have heard some buzz about yet another new antidepressant undergoing clinical trials, this one with the less-than-sexy name ALKS-5461. Some news outlets have promoted it as “revolutionary.” What exactly is it?
Trip Gardner, MD
Chief of Psychiatry, Penobscot Community Health Care Medical Director, Penobscot Community Health Care Homeless Services
Dr. Gardner has disclosed that he has no relevant relationships or financial interests in any commercial company pertaining to this educational activity.
The health care system seems to be evolving towards the integration of primary and mental health care. What are the benefits of this model and how will it affect psychiatrists?
1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...